Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Fortune Brands Innovations director, Edward P. Garden, recently purchased a substantial amount of the company's common stock, totaling over $2 million. This insider buying activity occurs while the stock is trading near its 52-week low and following disappointing Q1 earnings reports for the corporation. The purchase suggests internal belief in the …
FormFactor's director, Thomas St. Dennis, recently divested common stock worth $115,839. This transaction occurred against a backdrop of strong corporate performance, as the company announced first-quarter 2026 financial results that beat analyst forecasts for both earnings and revenue. Following these robust reports, several major analyst firms ha…
![Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma](/public/uploads/articles/press-release-img.png)
Perspective Therapeutics, Inc. announced that it will present updated data from all three of its clinical programs—[212Pb]VMT-b1-NET for neuroendocrine tumors, [212Pb]VMT01 for melanoma, and [212Pb]PSV359 for solid tumors—at the 2026 ASCO Annual Meeting. The data show continued favorable safety profiles, evidence of tumor response, and no dose-lim…
Deckers Outdoor raised its fiscal 2027 revenue and earnings targets above Wall Street estimates, driven by continued strength at its Hoka and UGG brands and growth across wholesale and direct-to-consumer channels. The company reported quarterly sales and profit that exceeded analyst expectations and highlighted product innovation and brand investme…
The analysis covers notable activity involving ProCap Financial's leadership, including an executive sale of shares. Concurrently, the company has signaled significant strategic developments through a major acquisition in AI and substantial open market share buybacks, suggesting efforts to bolster its operational scope and financial standing.
Cursor's run-rate revenue reached $3 billion in late April, up from $2 billion in February, driven by more than 3,000 enterprise customers paying at least $100,000 annually. The AI coding software firm released Composer 2.5 this week and remains subject to an agreement that gives SpaceX the right to buy the company for $60 billion or pay a $10 bill…
Goldman Sachs has agreed to a $500 million settlement with a class of shareholders who accused the bank of misleading investors about its involvement with 1MDB. The amount was disclosed in a Manhattan federal court filing and requires judicial approval. The settlement follows prior government penalties and criminal probes tied to the 1MDB scandal.
Adam Eltoukhy, an Executive Vice President and Chief Administrative Officer at Samsara Inc., sold a total of 5,473 shares of the company's Class A Common Stock on May 20, 2026, through transactions executed under a Rule 10b5-1 trading plan. The sales occurred while the stock traded near the weighted-average sale prices. Despite this insider activit…
The recent activity surrounding Old Second Bancorp Inc (OSBC) includes insider selling by Vice Chairman Gary S. Collins and the release of first-quarter financial results for 2026. While Mr. Collins sold shares totaling $211,200, the company's Q1 EPS of $0.48 fell short of analysts' expectations of $0.51. However, OSBC managed to exceed revenue for…
Black Rock Coffee Bar's Chief Marketing Officer, Jessica Wegener-Beyer, recently acquired a significant block of the company's stock. This insider activity occurs while BRCB is trading near its annual low. Furthermore, recent financial reporting showed that although the company posted robust revenue growth, earnings per share fell below analyst exp…
CRISPR Therapeutics ($CRSP) is priced like a growth story with a $4.8B market cap while the market waits on several clinical readouts and label expansion that could re-rate the shares. This trade idea lays out a long bias with an entry at $49.90, a stop at $40.00 and a $85.00 target tied to positive Phase 2/Phase 1 data and commercial progress.
Anthony Shea Treadway, Senior Vice President and Chief Revenue Officer at Trinet Group, Inc. (TNET), conducted a sale of company common stock totaling $40,548 on May 19, 2026. This transaction occurred against a backdrop of recent market volatility for TNET shares. Separately, the company reported strong first-quarter financial results for 2026, wi…
Director Lesa B. Roe of Solid Power, Inc. (NASDAQ:SLDP) sold shares valued at $104,290 as part of a pre-arranged trading plan on May 20, 2026. This transaction occurred alongside her acquisition of restricted stock units (RSUs). These movements take place against a backdrop of notable volatility for SLDP stock, which recently reported an earnings p…
Zentalis Pharmaceuticals announced encouraging Phase 1b clinical trial results from their MUIR study evaluating the investigational WEE1 inhibitor azenosertib combined with paclitaxel in platinum-resistant ovarian cancer patients. The combination showed a manageable safety profile and promising anti-tumor activity, notably a 39% overall response ra…
Sophie C. Ames, EVP and CHRO at D-Wave Quantum Inc., executed a sale of company common stock totaling $436,933 on May 20, 2026. The transaction occurred under an established Rule 10b5-1 trading plan. Separately, the company reported its Q1 2026 earnings, which showed an EPS of -$0.05, surpassing analyst expectations of -$0.08, though revenue fell s…
William Radford Lovett II, a 10% owner of Dream Finders Homes, Inc., recently sold shares valued at approximately $1.9 million over two days. This insider activity occurs as the company navigates various corporate developments, including an acquisition proposal for Beazer Homes and a change in its independent auditor.
Zoom Communications raised its fiscal 2027 revenue and adjusted EPS guidance and approved an additional $1 billion share repurchase program, citing stronger demand tied to newly integrated AI agents and companions. The company posted first-quarter revenue that beat expectations, while its second-quarter guidance sits marginally below some analyst e…
Shares of Peloton Interactive and Universal Technical Institute climbed in after-hours trading after S&P Dow Jones Indices announced their inclusion in the S&P SmallCap 600. The changes take effect prior to the opening on May 27, with Peloton replacing Enviri Corp. and Universal Technical Institute taking the slot held by Veris Residential. The mov…
Skyward Specialty Insurance Group's director, Anthony J. Kuczinski, recently purchased a significant block of the company's common stock through transactions reported to the Securities and Exchange Commission. This insider activity occurs against a backdrop of positive financial disclosures from Skyward Group, which reported Q1 2026 earnings that s…
Mexican stocks closed lower on Thursday, driven by losses in the Industrials, Consumer Goods & Services and Consumer Staples sectors. The S&P/BMV IPC ended the session down 0.74% while a handful of names outperformed and others posted notable declines. Market breadth was negative and key commodity and currency benchmarks showed modest changes.
Crescent Biopharma announced the presentation of a trial in progress poster for their ASCEND Phase 1/2 global clinical trial of CR-001, a PD-1 x VEGF bispecific antibody targeting multiple solid tumors including NSCLC, gastrointestinal and gynecological cancers. Enrollment is ongoing worldwide, with initial clinical data expected starting Q1 2027. …
Peace Acquisition Corp has priced its initial public offering of 6 million units at $10 per unit valuing the IPO at $60 million. The units will trade on Nasdaq under the ticker PECEU starting May 22, 2026. The company is a blank check acquisition company aiming to target business combinations primarily in Asia, excluding Mainland China, Hong Kong, …
Pliant Therapeutics announced a poster presentation at the 2026 ASCO Annual Meeting highlighting their Phase 1b FORTIFY trial, which is evaluating PLN-101095, a dual integrin inhibitor, in combination with pembrolizumab for patients with immune checkpoint inhibitor refractory solid tumors. The trial is actively enrolling multiple patient cohorts an…
A syndicate of Wall Street banks led by JPMorgan has enlarged a loan package for Warner Bros Discovery to exceed $10 billion as the company moves to refinance debt in advance of a planned merger with Paramount Skydance. The U.S. dollar term loan was raised to $9 billion from $5 billion while a 1 billion euro facility remains unchanged. The financin…
A director at Boston Scientific Corp (NASDAQ:BSX) recently purchased a substantial block of common stock. This insider activity occurs against a backdrop of significant corporate developments for the firm, including positive results from key clinical trials, large-scale strategic investments, and multiple favorable analyst ratings.
